Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Novonesis

433.60 DKK-0.69 %7.9. klo 10.21
Less than 1K followers

NSIS B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-0.69 %
+2.05 %
+18.11 %
+19.28 %
+6.33 %
+5.83 %
+41.56 %
-12.95 %
+1,071.89 %

Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.

Read more
Market cap
203.05B DKK
Turnover
10.95M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
11.2.
2027

Annual report '26

All
Research
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release02.09.2026 klo 10.38

Novonesis to build next generation enzyme production facility in India

Novonesis
Regulatory press release25.08.2026 klo 10.12

Trading by management and close relations of management

Novonesis
Press release19.08.2026 klo 19.25

H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook

Novonesis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Analyst Comment19.08.2026 klo 19.24

HCA Red Flag: Novonesis raises guidance and initiates a 1 BEUR share buyback (AI)

Expect a positive opening. Novonesis raised its full-year growth guidance to 7-8% vs. the 6.9% analysts expected and announced its first share buyback of 1 BEUR. EUR. The counterweight is the largest division, Agriculture, Energy & Tech, which grew by 7% vs. the expected 8.6%.

Novonesis
Regulatory press release19.08.2026 klo 18.41

Interim report H1 2026

Novonesis
Regulatory press release19.08.2026 klo 18.41

Announcement of share buyback program

Novonesis
Regulatory press release19.08.2026 klo 18.39

Increased outlook for 2026

Novonesis
Press release10.08.2026 klo 10.24

Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities

Novonesis
Regulatory press release06.05.2026 klo 15.44

Trading by management and close relations of management

Novonesis
Regulatory press release05.05.2026 klo 08.58

Interim report Q1 2026

Novonesis
Regulatory press release26.03.2026 klo 15.44

Trading by management and close relations of management

Novonesis
Regulatory press release23.03.2026 klo 18.54

Resolutions from the Annual General Meeting 2026

Novonesis
Regulatory press release23.03.2026 klo 14.52

Trading by management and close relations of management

Novonesis
Press release16.03.2026 klo 14.14

Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

Novonesis
Press release13.03.2026 klo 10.56

Novonesis issues EUR 1.7 billion senior unsecured notes

Novonesis
Regulatory press release11.03.2026 klo 14.38

Trading by management and close relations of management

Novonesis
Regulatory press release27.02.2026 klo 11.22

Trading by management and close relations of management

Novonesis
Regulatory press release26.02.2026 klo 18.04

Trading by management and close relations of management

Novonesis
Regulatory press release26.02.2026 klo 13.00

Invitation to the 2026 Annual General Meeting

Novonesis
Regulatory press release26.02.2026 klo 12.23

Trading by management and close relations of management

Novonesis